Uber Technologies, Blackstone And A Major Healthcare Company: CNBC's 'Final Trades'

Zinger Key Points
  • Karen Firestone of Aureus Asset Management said Blackstone is on the uptrend.
  • Joseph Terranova of Virtus Investment Partners named clinical research company ICON Public.

On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said Uber Technologies, Inc. UBER will have exceptional growth in 2024.

Uber signed a multi-year global deal with PayPal Holdings Inc PYPL, deepening PayPal's role as a critical strategic partner.

Karen Firestone of Aureus Asset Management said Blackstone Inc. BX is on the uptrend and was added to the S&P 500 recently. With interest rates peaking, this is a good time to buy the stock, she added.

Don’t forget to check out our premarket coverage here

Blackstone recently disclosed that its Tactical Opportunities business closed the fourth flagship commingled fund, Blackstone Tactical Opportunities Fund IV (BTO IV), raising a record capital commitment of $5.2 billion.

Joseph Terranova of Virtus Investment Partners named ICON Public Limited Company ICLR, a clinical research company with a $21 billion market cap.

ICON said it is partnering with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to execute a clinical trial to evaluate the effectiveness of next generation COVID-19 vaccine candidates.

Price Action: ICON shares gained 3% to close at $265.10, while Blackstone shares rose 0.2% to settle at $112.75 on Wednesday. Uber’s stock rose 0.5% to settle at $48.16 on Wednesday.
Check This Out: Adobe, Semtech And 3 Stocks To Watch Heading Into Thursday

Image courtesy of Uber

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!